Module Name Drug Therapeutic and Side-Effects Monitoring 
Module Level, If Applicable 4th Year
Code, If Applicable SFA-987
Semester (S) In Which The Module Is Taught Seventh Semester
Person Responsible For The Module Dr. Apt. Vitarani Dwi Ananda Ningrum, M.Si
Lecturer(S) Dr. Apt. Vitarani Dwi Ananda Ningrum, M.Si
Language English-Indonesian
Relation To Curriculum Elective Courses
Types Of Teaching And Learning Class Size Attendance Time (Hours Per Week Per Semester) Forms Of Active Participation Workload
Teaching 50 2 Lectures  Lectures: 2 (Hours) X 14 (Meeting) 28
Preparation And Follow Up: 4 (Hours) X 14 (Self-Learning) 56
Group Discussion 50 1 Case-Studies And Report Writing Practical: 1 (Hours) X 12 (Meeting) 12
Preparation And Follow Up: 2 (Hours) X 12 (Self-Preparation) 24
Total Workload 120 Hours
ECTS 4.29 ECTS
Credit Points 3 CU
Requirements According To Examination Regulations Minimum Attendance At Lectures Is 75% (According To Uii Regulation). Final Score Is Evaluated Based On Assignment And Reports (40%), Mid Semester Exam (30%), And End Semester Exam (30%).   
Recommended Prerequisites Therapeutic Concepts 
Related Course
Module Objectives/Intended Learning On Successful Completion Of The Course Students will be able to

  1. understand and    apply the attitude of responsibility,dedication,  and disciplinary  in  carrying out  lectures  and  completing well-given  lecture  assignments.   
  2. critically appraisal  against various EBM drug side    effects events  correctly  
  3. distinguish  between the responsibilities  of the pharmaceutical  industry  and  health  workers  in  health facilities  related to the    safety of drug  use
  4. explain the definitions, objectives, and forms  and parameters  oftreatment therapy  as  part of  the pharmacist’s  responsibility    in the field  of  services  to  support safe  and  effective  treatment
  5. distinguish  between  pharmacovigilance,  drug  side effects  with adverse drug reaction  and  adverse event.
  6. associate  therapeutic  monitoring  and  drug  side effects  in  cases of real  patients  with  nervous system    disorders,  gastrointestinal  and  respiratory  diseases,   diseases  of the  hormone-endocrine system,   diseases/disorders of the renal-cardiovascular system, and  infectious-malignant diseases.
Content
  • Pharmaceutical care 
  • Pharmacovigilance
  1. Treatment therapy  monitoring
  2. Drug  Side Effects
  3. Real patient cases
Study And Examination Requirements And Forms Of Examination Mid-Term, Final Term, Group Paper
Media Employed Slides (Power Points), And Video
Reading Lists
  1. Robert J. Cipolle, Linda M. Strand, Peter C. Morley , Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management Services, 3e, 2012,  McGraw-Hill Medical
  2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853665/
  3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853674/
  4. Evidence Based Medicine – New Approaches and Challenges, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789163/
  5. Various journal sites (www.nejm.org  ; www.bmj.com  journal ; www.cochrane.org;  https://ebm.bmj.com/